Bloomberg Sanofi SA agreed to buy Bioverativ Inc., a spinoff from biotech giant Biogen Inc., for about $11.6 billion in a bid by France’s biggest drugmaker to gain treatments for rare blood disorders. The deal values haemophilia drugmaker Bioverativ at $105 a share, according to a statement from Sanofi. Sanofi shares fell 2.6 percent to 71.05 euros at 9:18 am ...

Bloomberg For the modern foreign-exchange trader, it’s now possible to find a date, hail a cab and trade $100 million—all through their mobile phone. The world’s biggest financial market is embracing the iPhone era as investors find new ways to work when they’re not on the trading floor. In a JPMorgan Chase & Co. survey of more than 400 institutional ...

Bloomberg Financial markets in Britain and the EU will face instability and significant business disruption if the UK exits the EU in March 2019 without a transition deal or final settlement on a number of crucial issues, a finance industry trade group warned. There are at least five key areas where financial firms need clarity from UK and EU policymakers ...